feed,title,long_url,short_url
BioRxiv,Multivalency transforms SARS-CoV-2 antibodies into broad and ultrapotent neutralizers,https://biorxiv.org/cgi/content/short/2020.10.15.341636v1?rss=1,https://j.mp/3k5xGu5
BioRxiv,Duple extinguishment of COVID-19: single compound synergized inhibition of SARS-CoV-2 replication and direct suppression of inflammatory cytokines in vitro/vivo,https://biorxiv.org/cgi/content/short/2020.10.16.342097v1?rss=1,https://j.mp/2T3FtfP
BioRxiv,Additional analyses exploring the hypothesized transdifferentiation of plasmablasts to developing neutrophils in severe COVID-19,https://biorxiv.org/cgi/content/short/2020.10.15.339473v1?rss=1,https://j.mp/3nSUuzv
BioRxiv,Early induction of SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients,https://biorxiv.org/cgi/content/short/2020.10.15.341958v1?rss=1,https://j.mp/3lYzNAp
BioRxiv,Antibody Response to a Nucleocapsid Epitope as a Marker for COVID-19 Disease Severity,https://biorxiv.org/cgi/content/short/2020.10.15.341743v1?rss=1,https://j.mp/3lV37HO
BioRxiv,Abnormal Antibodies to Self-Carbohydrates in SARS-CoV-2 Infected Patients,https://biorxiv.org/cgi/content/short/2020.10.15.341479v1?rss=1,https://j.mp/2SYqe7Y
BioRxiv,Peptide vaccine candidate mimics the heterogeneity of natural SARS-CoV-2 immunity in convalescent humans and induces broad T cell responses in mice models,https://biorxiv.org/cgi/content/short/2020.10.16.339937v1?rss=1,https://j.mp/344uAka
BioRxiv,Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro,https://biorxiv.org/cgi/content/short/2020.10.16.342410v1?rss=1,https://j.mp/37e9WjR
